{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.499","meta":{"versionId":"11","lastUpdated":"2022-03-02T18:03:50.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.499","version":"20140630","name":"Influenza Vaccination Administration","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"Lantana","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.497"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.498"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2460"]}]},"expansion":{"identifier":"urn:uuid:fa4e8ea3-8284-422a-9944-be55c227ad30","timestamp":"2022-06-10T08:49:12-04:00","total":5,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"33879002","display":"Administration of vaccine to produce active immunity (procedure)"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0134Z","display":"Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0234Z","display":"Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"86198006","display":"Administration of vaccine product containing only Influenza virus antigen (procedure)"},{"system":"http://hl7.org/fhir/sid/icd-9-cm","version":"2013","code":"99.52","display":"Prophylactic vaccination against influenza"}]}}